Prescribed by US-licensed clinicians. Compounded by licensed US pharmacies.
RxPeptides

Weight loss

Finally lose the weight.

GLP-1s and metabolic support, prescribed by real clinicians and personalized to your body.

US-licensed clinicians

Compounded by licensed US pharmacies

Personalized protocols

Cold-chain shipping

US-licensed clinicians

Compounded by licensed US pharmacies

Personalized protocols

Cold-chain shipping

Weight loss products

Most effective
Tirzepatide vial

Tirzepatide injections

Dual-action GLP-1 and GIP, formulated for weight loss support.

Starting at $245/month

  • Significant weight loss*
  • Supports slower digestion
  • May help curb appetite
  • Supports blood sugar regulation
  • Easy use
Most popular
Semaglutide vial

Semaglutide injections

Weekly GLP-1 designed to support your weight loss goals.

Starting at $175/month

  • Significant weight loss*
  • Supports slower digestion
  • May help curb appetite
  • Supports blood sugar regulation
  • Easy use
Energy supportWeight loss
MIC B12 vial

MIC B12 injections

Metabolic and energy support for the long game.

Starting at $115/month

  • May help curb appetite
  • Metabolic support
  • Supports focus and clarity
  • Energy support

Compare

Which is right for you?

A quick read on how the three compare. Your clinician makes the final call.

 TirzepatideSemaglutideMIC B12
Best forSignificant weight lossSteady, sustainable weight lossEnergy and metabolic support on a cut
MechanismGLP-1 and GIP dual agonistGLP-1 agonistLipotropic blend + B12
IntensityHighMediumLow / supportive
Starting price$X/month$X/month$X/month

Questions

Questions about weight loss with peptides.

In clinical trials of FDA-approved GLP-1 medications, semaglutide produced an average of about 15% body-weight loss over 68 weeks, and tirzepatide up to about 21% over 72 weeks. Compounded GLP-1s are not FDA-approved and were not studied in those trials, so results are not guaranteed. MIC B12 is a supportive product, not a primary weight-loss driver. Your clinician will set realistic expectations for your body and your goal.
Both quiet appetite and slow digestion. Semaglutide is the single-action option. Tirzepatide adds a second receptor, GIP, which tends to mean more loss for some people. Your clinician weighs your history and your goal, then recommends the right fit.
Compounded GLP-1s use the same active ingredients as their brand-name counterparts, prepared by licensed US compounding pharmacies for your individual prescription. They are not FDA-approved, and they are dispensed only after a licensed clinician reviews your health history. Every order is prescription-gated, and your clinician stays available if anything feels off.
Most side effects are digestive, nausea, reduced appetite, constipation, and they tend to be strongest early, then settle as your body adjusts. Starting low and increasing slowly keeps them manageable for most people. Serious reactions are rare. Your clinician walks you through what to watch for and adjusts your dose if you need it.
There's no fixed end date. Many people stay on a GLP-1 through their loss phase, then move to a lower maintenance dose to hold their results. Others taper off entirely with their clinician's guidance. It's an ongoing conversation with your care team, not a decision you lock in on day one.

Join the waitlist.

We’re opening to new members soon. Drop your email to be first in line.